A low tendency toward expression of FOXN3 was detected in the ALL group (1.16±0.65), but the expression was not significantly different from the controls nor the AML groups (p>0.05) (Figure S2 in File S1). This evidence concerns the gene FOXN3 and acute myeloid leukemia.